In its report, Muddy Waters Capital, a short selling firm, described two types of attacks against St. Jude’s cardiac devices — one is a “crash” attack that causes malfunction and the other is a “battery drain” attack, proving harmful to those who are dependent on the devices. Low-level hackers could conduct both types of attacks on the devices, noted the Muddy Waters report. If the products were to be recalled, St. Jude could experience a 50 percent decrease in revenue for the next two years, according to the report.
If the Muddy Waters allegations are proven, Abbott Laboratories’ planned acquisition of St. Jude Medical could be derailed, Bloomberg reported.
“The allegations are absolutely untrue,” Phil Ebeling, St. Jude’s chief technology officer told Bloomberg. “There are several layers of security measures in place.”
Abbott officials did not offer any comments.
More articles on health IT:
OZ Systems, MDH, CDC to present findings on newborn screening
Johnson Controls, Methodist Healthcare sign $12.9M technology contract
CGI Group’s CONNECT Gateway can be used in Sequoia Project’s eHealth Exchange
